| MSD Merck Sharp & Dohme AG - Cubicin 350 mg, Pulver zur Herstellung einer Injektions-/Infusionslösung |
| 57870 | | 01 | | Cubicin 350 mg | | Pulver zur Herstellung einer Injektions-/Infusionslösung | | J01XX09 | | Daptomycin | | 03.04.2007 | | |
|
| Composition |
| Praeparatio cryodesiccata: daptomycinum 350 mg, natrii hydroxidum q.s. ad pH, pro vitro corresp. natrium 0.6 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Dry substance | | | | | | | | Active Agent | Dose |
|---|
| Daptomycin | 350 mg |
| | BAG: Active Agent | Dose |
|---|
| Daptomycin | 350 mg |
| | | | Inactive agents |
|---|
| Sodium Hydroxide |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 81.78 | 104.90 | A | SL | Yes |
|
